ZA888241B - Process for the synthesis of 3-thio-4-quinolene derivatives and intermediate compounds for use therein,and their use as medicaments - Google Patents

Process for the synthesis of 3-thio-4-quinolene derivatives and intermediate compounds for use therein,and their use as medicaments

Info

Publication number
ZA888241B
ZA888241B ZA888241A ZA888241A ZA888241B ZA 888241 B ZA888241 B ZA 888241B ZA 888241 A ZA888241 A ZA 888241A ZA 888241 A ZA888241 A ZA 888241A ZA 888241 B ZA888241 B ZA 888241B
Authority
ZA
South Africa
Prior art keywords
quinolene
medicaments
thio
synthesis
derivatives
Prior art date
Application number
ZA888241A
Other languages
English (en)
Inventor
Lachlan Maclean
Maclean Lachlan
David Lloyd Roberts
Lloyd Roberts David
Kenneth Barron
Barron Kenneth
Kenneth John Nichol
John Nichol Kenneth
Albert Ernest Harrison
Ernest Harrison Albert
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ZA888241B publication Critical patent/ZA888241B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA888241A 1987-11-18 1988-11-03 Process for the synthesis of 3-thio-4-quinolene derivatives and intermediate compounds for use therein,and their use as medicaments ZA888241B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878726950A GB8726950D0 (en) 1987-11-18 1987-11-18 Chemical process

Publications (1)

Publication Number Publication Date
ZA888241B true ZA888241B (en) 1989-10-25

Family

ID=10627131

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA888241A ZA888241B (en) 1987-11-18 1988-11-03 Process for the synthesis of 3-thio-4-quinolene derivatives and intermediate compounds for use therein,and their use as medicaments

Country Status (28)

Country Link
US (2) US5011931A (es)
EP (2) EP0343206A1 (es)
JP (1) JPH02502013A (es)
KR (1) KR890701563A (es)
AT (1) ATE69221T1 (es)
AU (1) AU628305B2 (es)
BG (1) BG50157A3 (es)
CS (1) CS274487B2 (es)
DD (1) DD290188A5 (es)
DE (1) DE3866086D1 (es)
ES (1) ES2038310T3 (es)
FI (1) FI91063C (es)
GB (1) GB8726950D0 (es)
GR (1) GR3003378T3 (es)
HU (1) HU204511B (es)
IE (1) IE883366L (es)
IL (1) IL88358A (es)
MX (1) MX168918B (es)
NZ (1) NZ227008A (es)
PH (1) PH27439A (es)
PL (1) PL157191B1 (es)
PT (1) PT89024B (es)
RO (1) RO104615B1 (es)
SU (1) SU1766255A3 (es)
TW (1) TW204344B (es)
WO (1) WO1989004827A1 (es)
YU (1) YU46989B (es)
ZA (1) ZA888241B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
US6194433B1 (en) 1998-10-05 2001-02-27 Neal R. Cutler Sexual dysfunction in females
US6110489A (en) * 1998-05-01 2000-08-29 Cutler; Neal R. Use of quinolines and quinolones to treat male erectile dysfunction
US6132753A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6132757A (en) 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6303135B1 (en) 1999-07-08 2001-10-16 Neal R. Cutler Use of quinolines and quinolones to treat male erectile dysfunction
US6307050B1 (en) * 2000-08-29 2001-10-23 R. T. Alamo Venture I Llc Method of synthesizing flosequinan from 4-fluoroanthranilic acid
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6649764B2 (en) * 2001-10-25 2003-11-18 R. T. Alamo Ventures I, Llc Stereospecific enrichment of heterocyclic enantiomers
US6730790B2 (en) * 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920699A (en) * 1974-04-26 1975-11-18 Warner Lambert Co Process for the cyclization of aryl(methylsulfinyl)-methyl ketones and compounds produced thereby
US4192873A (en) * 1976-11-25 1980-03-11 Ciba-Geigy Corporation Anti-inflammatory 2-sulphonyl- (or -sulphinyl)-2'-aminoacetophenones
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
FR2532939A1 (fr) * 1982-09-13 1984-03-16 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
DE3578374D1 (de) * 1984-01-13 1990-08-02 Boots Co Ltd Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process

Also Published As

Publication number Publication date
FI893405A (fi) 1989-07-13
CS748988A2 (en) 1990-09-12
YU209788A (en) 1990-08-31
DD290188A5 (de) 1991-05-23
FI893405A0 (fi) 1989-07-13
US5011931A (en) 1991-04-30
JPH02502013A (ja) 1990-07-05
FI91063C (fi) 1994-05-10
PL275880A1 (en) 1989-06-12
EP0317149A1 (en) 1989-05-24
WO1989004827A1 (en) 1989-06-01
ATE69221T1 (de) 1991-11-15
EP0317149B1 (en) 1991-11-06
KR890701563A (ko) 1989-12-21
IL88358A (en) 1993-02-21
BG50157A3 (en) 1992-05-15
PT89024B (pt) 1993-02-26
RO104615B1 (en) 1992-11-03
FI91063B (fi) 1994-01-31
HUT53085A (en) 1990-09-28
NZ227008A (en) 1991-10-25
TW204344B (es) 1993-04-21
ES2038310T3 (es) 1993-07-16
MX168918B (es) 1993-06-14
SU1766255A3 (ru) 1992-09-30
YU46989B (sh) 1994-09-09
US5079264A (en) 1992-01-07
EP0343206A1 (en) 1989-11-29
GB8726950D0 (en) 1987-12-23
HU204511B (en) 1992-01-28
CS274487B2 (en) 1991-04-11
GR3003378T3 (en) 1993-02-17
AU2616388A (en) 1989-06-14
PH27439A (en) 1993-07-02
PT89024A (pt) 1988-12-01
IE883366L (en) 1989-05-18
PL157191B1 (pl) 1992-05-29
DE3866086D1 (de) 1991-12-12
IL88358A0 (en) 1989-06-30
AU628305B2 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
GR3003378T3 (en) Process for the synthesis of 3-thio-4-quinolone derivatives and intermediate compounds for use therein, and their use as medicaments
DK0412404T3 (da) Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
GR3004139T3 (es)
FI893570A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
DK46884A (da) 5-aminomethyl-imidazol-1-yl-1,3-dialkyl-1h-pyrazol-4-yl-aroyl-methanoner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK669388D0 (da) Azolderivater
GR3002699T3 (en) Process for stabilising procaterol
PT73948A (en) Process for the preparation of biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
MY104164A (en) Heterocyclic compounds.
DE3775905D1 (de) Purin-histamin-h1-antagonisten, ihre herstellung und sie enthaltende pharmazeutische praeparate.